Lille (France), Cambridge (Massachusetts - USA), February 7, 2010, Naturalpha, international consulting, scientific and clinical research company in Nutrition and Health, partner of the Food and Pharmaceutical Industries, presents its analysis of the health claims dossiers reviewed by EFSA in order to allow food manufacturers to focus on potential generic health claims opportunities and to build an efficient R&D and health claim applications strategy.
In October, a third batch of scientific opinions for the ”general function” health claims (mentioned as 13.1) based on the work of EFSA’s NDA experts panel was published. It revealed 75 opinions related to 808 claims, bringing the number of claims assessed to 1745 on a total of 4637 health claims included in a list drawn up by the Member States of the European Commission. Despite 85% are negative opinions, the claims approved by EFSA still provide a wide range of opportunities to be explored by food Industrials. The European Commission will publish in 2012, after EFSA has evaluated all generic claims, a European register which will establish a definitive list of approved generic claims.
The deadline for analysis of generic claims requests which has been extended, together with the uncertainty about the nutrient profiles, create a latency period in the Nutrition & Health sector. But how can manufacturers take advantage of this delay to better prepare? How can they take advantage of generic claim opportunities to be more reactive?
Naturalpha, as an expert both in the field of regulatory and scientific substantiation of health benefits, has an added value for manufacturers wishing to position themselves successfully in the Nutrition & Health field. Our experts can advise at the very early stage of the project to assist industrials in the definition of the best health claim strategy adapted to their products and possibilities. Building on to our transversal expertise, we are able to provide key strategic information, such as investments and time delay required for various possible strategies, but also the associated risk of rejection, so they can make the appropriate decisions. Once the strategy of health claims chosen, Naturalpha can play an important role in its implementation, especially to build a solid health claim dossier based on conclusive evidence in humans. Relying on Naturalpha is an effective way to increase your success rate.
The full assessment is available on: http://www.naturalpha.com/
Key information provided:
- Exploit potential opportunities of generic claims
- Benefit of the uncertainties and often reported delays regarding the regulation
- Adopt a strategy for acceptance of your applications
- Be aware of the future major next steps in Nutrition and Health claims
About Naturalpha
Naturalpha, specialized in consulting, scientific and clinical research in Nutrition and Health, offers functional ingredients, food supplements and finished food manufacturers solutions to build a relevant research strategy. Naturalpha supports its industrial partners in building the proof of “health effect” of their innovative products at every stage of their development by proposing scientific and regulatory intelligence, consulting, health claim dossier audit, preclinical and clinical studies. In fact, Naturalpha has its own Clinical Nutrition Center, located within the Hospital Saint Vincent de Paul, a major hospital in the center of Lille (North of France), where it can conduct simultaneously several clinical studies in Nutrition.
Spin-off of the biotechnology company Genfit, Naturalpha is located in Lille with an office in Cambridge (Massachusetts, USA). Naturalpha employs 25 specialists (physicians, engineers, research scientists and dieticians) and is a member of the Nutrition Health Longevity Competitivity Cluster. www.naturalpha.com, www.cncn.naturalpha.com
Contacts:
NATURALPHA Marleen VAN D’HUYNSLAGER Phone: (+33) 3 20 95 95 08 marleen.vandhuynslager@naturalpha.com MILESTONES – PR Jacques-Olivier COSTA Phone: (+33) 1 75 44 87 42 jocosta@milestones.fr
